Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) (ADMIRE-CD-II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03279081
Recruitment Status : Recruiting
First Posted : September 12, 2017
Last Update Posted : September 26, 2019
Sponsor:
Information provided by (Responsible Party):
Takeda ( Tigenix S.A.U. )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 1, 2021
Estimated Study Completion Date : October 15, 2021